Show/Hide section Parameters and Transformations 
Date :   to     (DD-MM-YYYY)  
(Date settings applied on this page do not apply to other pages of the portal)
Transformation:

Series Level Information
Series Key SUP.Q.AT.W0._Z.I7600._T._Z._Z._Z._Z.PCT.C
Title Stage 3 loans and advances (% of loans and advances subject to impairment review)
Title Complement Stage 3 loans and advances (% of loans and advances subject to impairment review), Austria, World (all entities, including reference area, including IO), Percentage
Unit Percent
Dataset SUP : Supervisory Banking Statistics

Data Structure Definition (DSD)
Metadata page (Series and Dataset Level Information)
Show/Hide section More attributes
Data Chart
Chart is loading...
quick view chart

Legend  
CL_CONF_STATUS Observation Confidentiality
A Primary confidentiality due to small counts
C Confidential statistical information
D Secondary confidentiality set by the sender, not for publication
E Not for publication, restricted for internal use only (equivalent to the code N) until the embargo time elapses - free for publication (equivalent to the code F) after the embargo time elapses
F Free (free for publication)
G Primary confidentiality due to dominance by one or two units
M Primary confidentiality due to data declared confidential based on other measures of concentration
N Not for publication, restricted for internal use only
O Primary confidentiality due to dominance by one unit
S Secondary confidentiality set and managed by the receiver, not for publication
T Primary confidentiality due to dominance by two units

All non-Free observations are underlined.
Data Table
 Stage 3 loans and advances (% of loans and advances subject to impairment review), Austria, World (all entities, including reference area, including IO), Percentage
(Supervisory Banking Statistics)
Period valueobs. status
2022-Q31.96Normal value (A)
2022-Q22.07Normal value (A)
2022-Q12.11Normal value (A)
2021-Q42.18Normal value (A)
2021-Q32.18Normal value (A)
2021-Q22.30Normal value (A)
2021-Q12.45Normal value (A)
2020-Q42.53Normal value (A)
2020-Q32.34Normal value (A)
2020-Q22.29Normal value (A)